CLCA2 as a Novel Immunohistochemical Marker for Differential Diagnosis of Squamous Cell Carcinoma from Adenocarcinoma of the Lung

Figure 6

Impact of the CLCA2 expression level on the overall survival in patients with squamous cell carcinoma (SCC) of the lung. The survival curves in patients with SCC of the lung from the Hamamatsu University Hospital were generated using the Kaplan-Meier method. (a) The patients with SCC of the lung () were divided into a CLCA2 protein-positive group (red) and CLCA2 protein-negative group (blue), and the overall survival rates in the two groups were compared. ((b) and (c)) Female patients () (b) or male patients () (c) with lung SCC were divided into a CLCA2 protein-positive group (red) and CLCA2 protein-negative group (blue), and the overall survival rates in the two groups were compared.

(a)

(b)

(c)